Kristen K. Buck

Insider Reports History

Location
Basking Ridge, NJ
Signature
James Nisco, Attorney-in-Fact for Kristen K. Buck
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen K. Buck:

Company Role Class Num Shares Value Price $ Report Date Ownership
LISATA THERAPEUTICS, INC. EVP, R&D and CMO Common Stock 93,462 $184,120 $1.97 09 Jan 2026 Direct
LISATA THERAPEUTICS, INC. EVP, R&D and CMO Stock Option (Right to Buy) 13,000 09 Jan 2026 Direct

Insider Reports Filed by Kristen K. Buck

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2026 6 -$22,324 4 EVP, R&D and CMO 13 Jan 2026, 16:07
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2025 6 -$29,904 4 EVP, R&D and CMO 13 Jan 2025, 16:09
LSTA LISATA THERAPEUTICS, INC. 01 Oct 2024 2 +$25,306 4 EVP, R&D and CMO 02 Oct 2024, 17:21
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2024 5 -$18,069 4 EVP, R&D and CMO 11 Jan 2024, 16:11
LSTA LISATA THERAPEUTICS, INC. 01 Sep 2023 1 -$6,339 4 EVP, R&D and CMO 05 Sep 2023, 16:02
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2023 4 -$8,077 4 EVP, R&D and CMO 11 Jan 2023, 15:03
LSTA CALADRIUS BIOSCIENCES, INC. 01 Sep 2022 3 -$5,980 4 EVP, R&D and CMO 02 Sep 2022, 16:05
LSTA CALADRIUS BIOSCIENCES, INC. 10 Jan 2022 3 -$7,055 4 EVP, R&D and CMO 12 Jan 2022, 15:18
LSTA CALADRIUS BIOSCIENCES, INC. 01 Sep 2021 3 -$64,132 4 EVP, R&D and CMO 03 Sep 2021, 16:04
LSTA CALADRIUS BIOSCIENCES, INC. 01 Sep 2021 0 $0 3 EVP, R&D and CMO 03 Sep 2021, 16:02